Biotech-Focused Fund Adds Million: Immunome Bet Surges
A leading biotech-focused fund just boosted its Immunome position by a material amount as the stock surged. This arti...
Explore various work from home opportunities that can help you earn quick cash. Find flexible options that fit your schedule.
23,704 articlesA leading biotech-focused fund just boosted its Immunome position by a material amount as the stock surged. This arti...
A federal program combines government seed money with private donations to fund child investment accounts. This guide...
Trump’s tariff threat makes markets pivot, accelerating a rotation from U.S. stocks to international equities. The Va...
When a top executive at Yum China sells a large block of stock, investors pay attention. This article breaks down the...
Near protocol climbed in a double-digit rally, buoyed by a privacy-first upgrade. Traders debate whether the move sig...
Institutional moves can reveal much about a company’s future. This article breaks down why long path partners buys Al...
Three clinical-stage biotechs—UniQure, Syndax, and Erasca—are catching analyst attention ahead of key catalysts, with...
Geopolitics around Iran’s Strait Hormuz could reshape energy prices in Europe again. Here’s what households need to k...
Regulators move toward a sweeping U.S. crypto framework, boosting risk assets and shaping near-term price moves. Bitc...
A 1949 recording captures the oldest known humpback song off Bermuda, offering a window into an ocean once times quie...
Lumentum shares jumped about 12% on a $2 billion NVIDIA partnership, as AI data-center buildout and robust backlog un...
A Manhattan class-action accuses Gemini of misrepresenting its growth plan during its September IPO. Shares have fall...